Live news related to NICOX stock (FR0013018124): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on NICOX mainly cover M&A activity, earnings publications et share price moves. The stock trades at €0,38 on Euronext Paris, down 0,40% at the last update. This page lists the articles published on NICOX stock to track the share price, company announcements and any item likely to influence market perception.
On Wednesday, Kowa submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for NCX 470, Nicox's leading eye drop aimed at red…
Nicox announced on Tuesday the signing of a shareholder loan agreement with Vester Finance for €6 million over 36 months. This optional financing aims…
The biotech company from Biot (Alpes-Maritimes) sees a significant uptick in mid-morning trading on the Paris Stock Exchange. The stock is reacting to…
Ocumension Therapeutics, Nicox's exclusive partner in the Chinese market, received a favorable opinion from the Chinese health regulator (CDE) on Thur…
On Tuesday, Nicox reported a significant financial recovery in 2025 with a net loss reduced to €2.4 million from €22.4 million in 2024. This recovery …
Nicox shares are up 3.08% this Tuesday mid-day, trading at €0.4525, after closing the previous session at €0.44. This rebound follows a 5.63% decline …
Nicox's stock soared this Tuesday midday, boosted by the presentation of encouraging clinical data at a major scientific congress. The stock is up mor…
On Tuesday, Nicox unveiled favorable Phase 3 clinical data for NCX 470, its leading development program. These results were presented at the 2026 annu…
Nicox has announced receiving positive written feedback from the U.S. Food and Drug Administration (FDA) following its pre-NDA meeting on NCX 470, an …
Nicox SA, an international ophthalmology company, has confirmed its eligibility for the PEA-PME scheme for the upcoming year. This confirmation allows…
